This article was originally published on PEOPLE.Mariah Carey had a ball dropped on her on New Year’s Eve in the middle of New York City’s Times Square. Though it wasn’t in the way most would expect.
Subscribe to our daily newsletter for the latest in hair, beauty, style and celebrity news
The 46-year-old singer fumbled her way through three painfully awkward performances Saturday night, closing out Dick Clark’s New Year’s Rockin’ Eve with Ryan Seacrest — and 2016 — on a sour note.
She was the last pre-midnight guest on the ABC special — which included a performance by Fifth Harmony, pre-taped before Camila Cabello left the group. While those ladies were in sync, Carey was far less lucky.
Sounds problems plagued Carey’s appearance, beginning with her take on the New Year’s Eve classic “Auld Lang Syne.” Seconds into that number, it became clear Carey could not hear the backup vocals heard on the live broadcast, causing her to get flustered.
It didn’t get better as Carey moved into her second number of the evening: her 1991 hit “Emotions.” There, Carey barely sang, pausing to tell the audience “We didn’t have a [sound] check for this song, so we’ll just say it went to No. 1 and that’s what it is, okay?”
“Well, Happy New Year! We can’t hear, but I’ll just get through the moment,” she said.
Visibly frustrated, the Mariah’s World star walked around the stage — pausing and motioning for her ear piece (which she had removed earlier and tucked behind her shoulder with the help of a dancer). “Put these monitors on, please,” she pleaded with the production crew.
Twitter, of course, was in full force as the disaster unfolded.
Carey tried her best at the choreography “just for laughs,” and invited the audience to sing along at times — reminding them “we’re missing some of this vocal, but it is what it is.”
“I want a holiday, too. Can I not have one?” she asked at one point. “I’m trying to be a good sport here.”
As the song ended, Carey looked completely defeated — sarcastically telling the crowd, “That was… amazing.”
By the time the third song came around, it was clear Carey had run out of cares to give. “Now this is the album version,” she said as 2005’s “We Belong Together” began. “I’m just going… sing along with it. Well, not sing, but have a moment.”
Mouthing the words to the pre-recorded tracks, Carey called for her dancers to “bring the feathers on — yes!” Standing around them with their oversized props, she ended the performance telling the crowd “You Just don’t get any better.”
She clearly had a good sense of humor about the New Year’s Eve nightmare, tweeting a GIF of herself afterwards and writing: “S— happens. Have a happy and healthy new year everybody! Here’s to making more headlines in 2017.”
Did you know that APOL1-mediated kidney disease (AMKD) is a serious genetic disease that impacts people of African ancestry? AMKD affects thousands of Black women and men, however, it’s not yet widely known or diagnosed in the United States. Therefore, we want to recognize AMKD Awareness Day, held annually on the last Tuesday of April. Now is the perfect time to learn more about AMKD, have open conversations about your health with your family and doctor, and seek additional testing resources, if needed.
“This disease has a huge impact on my daily life,” said Emani McConnell-Brent, an advocate and ambassador for the American Kidney Fund (AKF), currently living with AMKD. “I don’t feel like I have the luxury to operate in the world like an average 21-year-old.”
While kidney disease is often regarded as an older person’s disease, Emani’s story is unsurprising once you learn that AMKD can develop at a young age in otherwise healthy people and can advance faster than other kidney diseases.
Chronic kidney disease is often regarded as a “silent” disease as it typically has no noticeable symptoms until the kidneys have declined dramatically, often necessitating kidney dialysis and potentially, a kidney transplant.
In the U.S., there are clear disparities among those affected by kidney disease. “People of all races and backgrounds can have kidney disease,” says LaVarne Burton, president and CEO of AKF. “But people of color are more likely to be affected by kidney failure.” Kidney disease affects one in seven American adults, however, the prevalence of end-stage kidney disease (kidney failure) among Black people in the U.S. is over four times that of White people.
One cause for the higher prevalence in kidney failure among Black Americans is genetics—specifically changes in the APOL1 gene. Everyone has two copies of the APOL1 gene (one from each parent), but people of Western and Central African ancestry are more likely to have changes (variants or mutations) in their APOL1 gene that can cause AMKD. An estimated 13% of Black Americans have the two APOL1 gene variants (mutations) that are associated with AMKD. “Those who have variants in both copies of the APOL1 gene have a one-in-five chance of developing kidney disease, therefore, it’s critically important for people who are Black, Afro-Caribbean, African American or Hispanic/Latino to be aware of AMKD and have kidney health conversations with their doctor,” explains LaVarne.
What to Look For
If you have not been diagnosed with chronic kidney disease but have started noticing symptoms such as uncontrolled high blood pressure, swelling, fatigue, headaches, foamy urine, itchy skin, and/or muscle cramps, talk to your doctor about whether you should get tested for kidney disease.
“For those at risk for AMKD, there are steps that can be taken to promote kidney and general health, including regular visits with your doctor, maintaining a healthy eating plan, taking all medicines as prescribed, being active at least 30 minutes a day most days of week, and avoiding tobacco,” says Pranav Garimella, chief medical officer, American Kidney Fund.
It’s important to note that people with APOL1 gene variants that cause AMKD are not guaranteed to develop kidney disease. “They should be aware of the possibility, and discussing kidney health and symptoms with their doctor, given that AMKD generally progresses to kidney failure more rapidly than kidney disease caused by other factors,” says LaVarne.
AMKD can present in a variety of ways—including (but not limited to) focal segmental glomerular sclerosis (FSGS), hypertension (blood pressure)-associated kidney disease, HIV-associated nephropathy and lupus nephritis. So, people who have already been diagnosed with a form of chronic kidney disease may have AMKD without knowing it, and the only way to confirm is through a genetic test.
If you have already been diagnosed with kidney disease, talk to your doctor about whether getting a genetic test to learn if you have the APOL1 genetic variants is the right next step.
Emani’s Story
Emani’s symptoms first appeared at 17 years old. Emani started having unexplained symptoms, leading to collapsing, and her mother rushed her to the emergency department. “I experienced edema, chronic fatigue, proteinuria, and stomach pain. However, records show that my pediatric physicians noticed I had had protein in my urine since I was seven years old, but it was ignored and said to be caused by an unhealthy diet,” says Emani. “At the point of hospitalization, that major symptom had been ignored for 10 years.”
At the hospital, Emani was given a diagnosis of kidney disease, and the nephrologist mentioned several possible causes of it, including lupus. The experience was frightening and so anxiety-inducing that Emani opted for a biopsy right then and there. When the results came back, she was diagnosed with focal segmental glomerulosclerosis (FSGS), a form of AMKD. “At that point, I thought my family and I had received all the answers we needed, but almost a year and three medications later, nothing was working,” says Emani. “My nephrologist suggested genetic testing, and I was diagnosed with AMKD as the root cause of my FSGS.”
Receiving this diagnosis has made a huge impact on Emani’s daily life. “Before class, I have to check my blood pressure, eat breakfast, take medications, check my legs for swelling, and put on compression socks if needed,” says Emani. “It has forced me to be transparent about my diagnosis with friends. While it’s normal for them to want to go out and have fun, I simply don’t have the same amount of energy as them.”
Emani McConnell-Brent with her mother, Shaquita Brent
Power Forward Together
Powering forward means taking action—having open conversations with family and your health care team about your health, family history of kidney disease and learning whether you’re at risk for developing AMKD.
If you have kidney disease, genetic testing is the only way to know if you have AMKD and deciding whether to have a genetic test is a personal decision. Knowing if you have AMKD can help you and your doctor decide how best to manage your disease and take care of your kidneys. While there are currently no medicines to treat the root cause of AMKD, new potential treatments for AMKD are being studied, and you may be eligible to participate in that research.
That’s why the American Kidney Fund launched AMKD Awareness Day to increase recognition of AMKD and encourage people to become APOL1 Aware. “We want people to better understand how their genes can impact their kidney health, and share that knowledge,” says LaVarne.
If you have AMKD, you may be able to take part in a clinical trial.
“This could provide an opportunity for researchers to investigate treatments for AMKD,” Pranav said.
“My plan moving forward is to stay focused, stay positive, and share my journey as it unfolds,” says Emani. “My advice is to pay attention to what your body is telling you, no matter how old or young you are.”
